Search

Your search keyword '"Smith, Trevor R.F."' showing total 35 results

Search Constraints

Start Over You searched for: Author "Smith, Trevor R.F." Remove constraint Author: "Smith, Trevor R.F."
35 results on '"Smith, Trevor R.F."'

Search Results

2. Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model

3. Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial

4. In vivo delivery of synthetic DNA-encoded antibodies induces broad HIV-1-neutralizing activity

8. Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates

9. Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection

11. Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates

12. SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial

13. One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model

14. Design, immunogenicity and efficacy of a Pan-SARS-CoV-2 synthetic DNA vaccine

15. Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure

17. Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets

18. INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants

19. Protection against Borreliella burgdorferi infection mediated by a synthetically engineered DNA vaccine

20. Intradermal-delivered DNA vaccine provides anamnestic protection in a rhesus macaque SARS-CoV-2 challenge model

21. SARS-CoV-2 assays to detect functional antibody responses that block ACE2 recognition in vaccinated animals and infected patients

23. In Vivo Delivery of a DNA-Encoded Monoclonal Antibody Protects Non-human Primates against Zika Virus

27. In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model

29. Protection against Borreliella burgdorferiinfection mediated by a synthetically engineered DNA vaccine

30. In VivoDelivery of a DNA-Encoded Monoclonal Antibody Protects Non-human Primates against Zika Virus

34. Revival of CD8+ Treg–mediated suppression

35. In VivoDelivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model

Catalog

Books, media, physical & digital resources